The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomy

masaki shiota, Akira Yokomizo, ario takeuchi, Kenjiro Imada, Keijiro Kiyoshima, Junichi Inokuchi, Katsunori Tatsugami, Seiji Naito

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background and Objective To examine the association between the features of metabolic syndrome (MetS) (obesity, hypertension, diabetes mellitus, and dyslipidemia) and the risk of biochemical recurrence (BCR) after radical prostatectomy in patients with prostate cancer. Methods This study included 283 Japanese patients with localized prostate cancer who were treated with radical prostatectomy between 2008 and 2012. Their oncological outcomes and the prognostic significance of several clinicopathological factors, as well as the features of MetS, were analyzed. Results Of 283 men who underwent radical prostatectomy, 49 (17.2%) subsequently developed BCR with a median postoperative follow-up of 14.8 months. Among the clinicopathological factors, prostate-specific antigen (PSA) level at diagnosis, pathological stage, pathological Gleason score, and lymph-node involvement were independent risk factors for BCR in multivariate analysis. In addition, the number of metabolic risk factors was also an independent risk factor for BCR. Conclusions The features of MetS were linked with poorer outcome after radical prostatectomy among Japanese men. Further investigations are needed to determine the effect of improving MetS on prostate cancer prognosis.

Original languageEnglish
Pages (from-to)476-481
Number of pages6
JournalJournal of Surgical Oncology
Volume110
Issue number4
DOIs
Publication statusPublished - Jan 1 2014

Fingerprint

Prostatectomy
Recurrence
Prostatic Neoplasms
Neoplasm Grading
Prostate-Specific Antigen
Dyslipidemias
Diabetes Mellitus
Multivariate Analysis
Obesity
Lymph Nodes
Hypertension

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomy. / shiota, masaki; Yokomizo, Akira; takeuchi, ario; Imada, Kenjiro; Kiyoshima, Keijiro; Inokuchi, Junichi; Tatsugami, Katsunori; Naito, Seiji.

In: Journal of Surgical Oncology, Vol. 110, No. 4, 01.01.2014, p. 476-481.

Research output: Contribution to journalArticle

@article{38c19ff69070455d8c6b164e9a2a99b6,
title = "The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomy",
abstract = "Background and Objective To examine the association between the features of metabolic syndrome (MetS) (obesity, hypertension, diabetes mellitus, and dyslipidemia) and the risk of biochemical recurrence (BCR) after radical prostatectomy in patients with prostate cancer. Methods This study included 283 Japanese patients with localized prostate cancer who were treated with radical prostatectomy between 2008 and 2012. Their oncological outcomes and the prognostic significance of several clinicopathological factors, as well as the features of MetS, were analyzed. Results Of 283 men who underwent radical prostatectomy, 49 (17.2{\%}) subsequently developed BCR with a median postoperative follow-up of 14.8 months. Among the clinicopathological factors, prostate-specific antigen (PSA) level at diagnosis, pathological stage, pathological Gleason score, and lymph-node involvement were independent risk factors for BCR in multivariate analysis. In addition, the number of metabolic risk factors was also an independent risk factor for BCR. Conclusions The features of MetS were linked with poorer outcome after radical prostatectomy among Japanese men. Further investigations are needed to determine the effect of improving MetS on prostate cancer prognosis.",
author = "masaki shiota and Akira Yokomizo and ario takeuchi and Kenjiro Imada and Keijiro Kiyoshima and Junichi Inokuchi and Katsunori Tatsugami and Seiji Naito",
year = "2014",
month = "1",
day = "1",
doi = "10.1002/jso.23677",
language = "English",
volume = "110",
pages = "476--481",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomy

AU - shiota, masaki

AU - Yokomizo, Akira

AU - takeuchi, ario

AU - Imada, Kenjiro

AU - Kiyoshima, Keijiro

AU - Inokuchi, Junichi

AU - Tatsugami, Katsunori

AU - Naito, Seiji

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background and Objective To examine the association between the features of metabolic syndrome (MetS) (obesity, hypertension, diabetes mellitus, and dyslipidemia) and the risk of biochemical recurrence (BCR) after radical prostatectomy in patients with prostate cancer. Methods This study included 283 Japanese patients with localized prostate cancer who were treated with radical prostatectomy between 2008 and 2012. Their oncological outcomes and the prognostic significance of several clinicopathological factors, as well as the features of MetS, were analyzed. Results Of 283 men who underwent radical prostatectomy, 49 (17.2%) subsequently developed BCR with a median postoperative follow-up of 14.8 months. Among the clinicopathological factors, prostate-specific antigen (PSA) level at diagnosis, pathological stage, pathological Gleason score, and lymph-node involvement were independent risk factors for BCR in multivariate analysis. In addition, the number of metabolic risk factors was also an independent risk factor for BCR. Conclusions The features of MetS were linked with poorer outcome after radical prostatectomy among Japanese men. Further investigations are needed to determine the effect of improving MetS on prostate cancer prognosis.

AB - Background and Objective To examine the association between the features of metabolic syndrome (MetS) (obesity, hypertension, diabetes mellitus, and dyslipidemia) and the risk of biochemical recurrence (BCR) after radical prostatectomy in patients with prostate cancer. Methods This study included 283 Japanese patients with localized prostate cancer who were treated with radical prostatectomy between 2008 and 2012. Their oncological outcomes and the prognostic significance of several clinicopathological factors, as well as the features of MetS, were analyzed. Results Of 283 men who underwent radical prostatectomy, 49 (17.2%) subsequently developed BCR with a median postoperative follow-up of 14.8 months. Among the clinicopathological factors, prostate-specific antigen (PSA) level at diagnosis, pathological stage, pathological Gleason score, and lymph-node involvement were independent risk factors for BCR in multivariate analysis. In addition, the number of metabolic risk factors was also an independent risk factor for BCR. Conclusions The features of MetS were linked with poorer outcome after radical prostatectomy among Japanese men. Further investigations are needed to determine the effect of improving MetS on prostate cancer prognosis.

UR - http://www.scopus.com/inward/record.url?scp=84905726352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905726352&partnerID=8YFLogxK

U2 - 10.1002/jso.23677

DO - 10.1002/jso.23677

M3 - Article

C2 - 24898352

AN - SCOPUS:84905726352

VL - 110

SP - 476

EP - 481

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 4

ER -